India, Dec. 12 -- Danish pharmaceutical company Novo Nordisk has finally launched its popular diabetes drug Ozempic in India, setting the price of the 0.25 mg starting dose at Rs.2,200 per week.

As per the report, the company will sell the injectable drug in the country in 0.25 mg, 0.5 mg and 1 mg strengths.

Notably, Ozempic is an injectable drug for type 2 diabetes and has to be taken once a week.

The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes. Since then, it has become a global bestseller and is often used off-label for weight loss due to its appetite-reducing effects.

The lowest dose of the drug will be sold at a price of Rs.2,200 per week. The company has also annou...